TL;DR: 64x Bio is a Y Combinator Summer 2018 startup Enabling next generation medicines. A comprehensive platform and…, currently active with a team of 25.
Enabling next generation medicines. A comprehensive platform and…
Last verified:
The future of medicine is taking shape, but scaling it remains a challenge. Some of the biggest breakthroughs in next generation therapies are being held back by manufacturing constraints. The science is moving fast, but the infrastructure is still catching up. Our VectorSelect platform is designed to unlock the scale these therapies need to survive. We combine massively parallelized screens with computational insights to engineer high yield cell lines and production technologies — accelerating the manufacturing of advanced therapies from the inside out.
Built by LemStudio
Yes. 64x Bio was funded by Y Combinator in the Summer 2018 batch. Enabling next generation medicines. A comprehensive platform and…
The future of medicine is taking shape, but scaling it remains a challenge. Some of the biggest breakthroughs in next generation therapies are being held back by manufacturing constraints. The science is moving fast, but the infrastructure is still catching up. Our VectorSelect platform is designed to unlock the scale…
64x Bio was part of Y Combinator's Summer 2018 batch.
64x Bio has a team of 25 people according to Y Combinator's directory.
64x Bio is currently listed as Active with a team of 25 in Y Combinator's directory.
Loading interactive view…